Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Denali Therapeutics (DNLI) Return on Assets (2018 - 2025)

Denali Therapeutics (DNLI) has disclosed Return on Assets for 8 consecutive years, with 0.47% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 17.0% to 0.47% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.47% through Dec 2025, down 17.0% year-over-year, with the annual reading at 0.41% for FY2025, 7.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.47% at Denali Therapeutics, down from 0.45% in the prior quarter.
  • The five-year high for Return on Assets was 0.04% in Q1 2021, with the low at 0.47% in Q4 2025.
  • Average Return on Assets over 5 years is 0.21%, with a median of 0.23% recorded in 2022.
  • Peak annual rise in Return on Assets hit 39bps in 2021, while the deepest fall reached -26bps in 2021.
  • Over 5 years, Return on Assets stood at 0.2% in 2021, then fell by -20bps to 0.24% in 2022, then surged by 50bps to 0.12% in 2023, then plummeted by -146bps to 0.3% in 2024, then crashed by -56bps to 0.47% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.47%, 0.45%, and 0.39% for Q4 2025, Q3 2025, and Q2 2025 respectively.